These findingsprovide indirect evidence of RBP4 involvement in cardiac remodeling and bring newinsights into the pathophysiological role of RBP4 which might be a promisingtherapeutic target for DCM. This evidence concerns the gene RBP4 and familial dilated cardiomyopathy.